Tiroid Fonksiyon Bozuklarında Kas İskelet Sistemi Bulguları
Özet
Tiroid fonksiyon bozuklukları ile kas iskelet sistemi arasındaki yakın ilişki, endokrin sistem patolojilerinin romatizmal ve nöromüsküler klinik bulgularla ne denli iç içe geçtiğini göstermektedir. Hipotiroidi vakalarında artropati, proksimal miyopati, karpal tünel sendromu (KTS), Dupuytren kontraktürü ve adeziv kapsülit (donuk omuz) gibi rahatsızlıklar sıklıkla karşımıza çıkmaktadır. Özellikle hyalüronik asit birikimi, eklem efüzyonlarına ve tünel içi hacmi artırarak median sinir sıkışmasına yol açmaktadır. Hipertiroidi durumunda ise osteoblastik ve osteoklastik aktivitelerin hızlanması yıkım lehine sonuçlanarak kemik mineral yoğunluğunda düşüşe, erken osteoporoza ve vertebra kırıklarına neden olmaktadır. Bununla birlikte hipertiroidide kas güçsüzlüğü, periartritler, nadir görülen tiroid akropatisi ve acil bir durum olan tirotoksik hipokalemik periyodik paralizi tablosu gelişebilmektedir. Son olarak romatoid artrit (RA), sistemik lupus eritematozus (SLE), Sjögren sendromu ve fibromiyalji gibi otoimmün romatizmal hastalıklar ile Haşimato ve Graves gibi otoimmün tiroid hastalıkları arasında yüksek bir birliktelik oranı ve ortak immunolojik mekanizmalar mevcuttur. Kollajen doku ve romatizmal hastalıkların takibinde tiroid testlerinin rutin olarak yapılmasının, eşlik eden patolojilerin erken tanısı ve etkin tedavi planlaması açısından kritik önem taşıdığı vurgulanmaktadır.
The close relationship between thyroid dysfunctions and the musculoskeletal system demonstrates how deeply endocrine pathologies intertwine with rheumatic and neuromuscular clinical findings. In cases of hypothyroidism, manifestations such as arthropathy, proximal myopathy, carpal tunnel syndrome (CTS), Dupuytren's contracture, and adhesive capsulitis (frozen shoulder) are frequently encountered. Specifically, the accumulation of hyaluronic acid leads to joint effusions and median nerve compression by increasing pressure within the carpal tunnel. Conversely, hyperthyroidism accelerates both osteoblastic and osteoclastic activities in favor of bone resorption, causing a decrease in bone mineral density, early osteoporosis, and vertebral fractures. Additionally, muscle weakness, periarthritis, rare thyroid acropachy, and thyrotoxic hypokalemic periodic paralysis—a medical emergency—can develop during hyperthyroidism. Lastly, a high prevalence of coexistence and shared immunologic mechanisms exists between autoimmune rheumatic diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Sjögren's syndrome, and fibromyalgia, and autoimmune thyroid diseases like Hashimoto's and Graves'. Routine thyroid screening in the follow-up of connective tissue and rheumatic diseases is strongly emphasized as critical for early diagnosis and effective treatment planning of these concurrent pathologies.
Referanslar
Anwar S, Gibofsky A. Musculoskeletal manifestations of thyroid disease. Rheumatic Disease Clinics of North America. 2010;36(4):637-646. doi: 10.1016/j.rdc.2010.09.001
Schmid C, Zwimpfer C, Brändle M, et al. 2006, Effect of thyroxine replacement on serum IGF‐I, IGFBP‐3 and the acid‐labile subunit in patients with hypothyroidism and hypopituitarism. Clinical Endocrinology. 2006;65(6),706-711
Yazıcı S, Yağlı M, Ataoğlu S. Romatizmal hastalıklarda tiroid fonksiyonları. Göztepe Tıp Dergisi. 2005;20:200-204
Duyff RF, Van den Bosch J, Laman DM, et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. Journal of Neurology, Neurosurgery and Psychiatry. 2000;68:750-755. doi: 10.1136/jnnp.68.6.750.
Akın S, İnanır A. Guatr Hastalarında Kas İskelet Sistemi Bulgularının Değerlendirilmesi. Cukurova Medical Journal. 2013;38(2):261-269.
Cronin M. Rheumatic aspect of endocrinopathies. In: Mc Carthy DJ. Arthritis and Allied Condition. Philadelphia: Lea and Febiger.1989;1842-59.
Tagoe CE, Zezon A, Khattri S. Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease. The Journal of Rheumatology. 2012;39(6):1125-1129. doi: 10.3899/jrheum.120022.
Chakravarty SD, Markenson jA. Rheumatic manifestations of endocrine disease. Current Opinion in Rheumatology. 2013;25(1):37-43. doi: 10.1097/BOR.0b013e32835b4f3f.
Dorwart BB, Schumacher HR. joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism. A clinicopathologic study. The American Journal of Medicine. 1975;59(6):780- 90. doi: 10.1016/0002-9343(75)90463-5.
Erickson AR, Enzenauer RJ, Nordstrom DM et al. The prevalance of hypothyroidism in gout. The American Journal of Medicine. 1994; 97:231-234. doi: 10.1016/0002-9343(94)90005-1.
Giordano N, Santacroce C, Mattii G, et al. Hyperuricemia and gout in thyroid endocrine disorders. Clinical and Experimental Rheumatology. 2001;19(6):661-665.
Sindoni A, Rodolico C, Pappalardo MA, et al. Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. Reviews in Endocrine and Metabolic Disorders. 2016;17(4):499-519. doi: 10.1007/s11154-016-9357-0.
Scott KR, Simmons Z, Boyer PJ. Hypothyroid myopathy with a strikingly elevated serum creatine kinase level. Muscle & Nerve. 2002;26(1):141-144. doi: 10.1002/mus.10128.
Brown D, Williams K, Cuccurullo S. Myopathies. In: Maitin IB, editor. CURRENT Diagnosis & Treatment: Physical Medicine & Rehabilitation. Mc Graw-Hill Education;2015.p.282-302. ISBN: 978-0-07-179330-8
Örük GG, Bahçeci M. Neuromuscular system findings in thyroid and parathyroid disease. Pamukkale Tıp Dergisi. 2013;6(2):108-117.
Caiozzo VJ, Baker MJ, Baldwin KM. Novel transitions in MHC isoforms: separate and combined effects of thyroid hormone and mechanical unloading. Journal of Applied Physiology (1985). 1998;85(6):2237-2248. doi: 10.1152/jappl.1998.85.6.2237.
Klein I, Parker M, Shebert R, et al. Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome. The American Journal of Medicine. 1981;70(4):891-894. doi: 10.1016/0002-9343(81)90550-7.
Tullu MS, Udgirkar VS, Muranjan MN, et al. Kocher-Debre-Semelaigne syndrome: hypothyroidism with muscle pseudohypertrophy. Indian Journal of Pediatrics. 2003;70(8):671-673. doi: 10.1007/BF02724260.
Bengston KA, Brault JS. Hand Disorders. In: Delisa J A, editor. Physical Medicine & Rehabilitation Principles and Practice. 3th ed. USA: Lippincott Williams & Wilkins; 2005. p. 843-54.
Özçete ZA, Öztürk C, On AY, et al. Effect of Short Wave Therapy in Idiopathic Carpal Tunnel Syndrome: A Randomized Double-Blind Controlled Study. Turkish Journal of Physiotherapy and Rehabilitation. 2013;59:103-7. doi: 10.4274/tftr.05657
Ertekin C. Pleksus Brakiyalisten Çıkan Sinirler. In: Ertekin C, editor. Santral ve Periferik EMG AnatomiFizyoloji-Klinik. İzmir: Meta Basım Matbaacılık. 2006;387–453.
Katz JN, Larson MG, Sabra A, et al. The carpal tunnel syndrome: diagnostic utility of the history and physical examination findings. Annals of Internal Medicine. 1990;112(5):321-327. doi: 10.7326/0003-4819-112-5-321.
Frymoyer JW, Bland J. Carpal-tunnel syndrome in patients with myxedematous arthropathy. The Journal of Bone and Joint Surgery. 1973;55(1):78-82.
Beard L, Kumar A, Estep HL. Bilateral carpal tunnel syndrome caused by Graves' disease. Archives of Internal Medicine. 1985;145(2):345-346. PMID: 3838432.
Uğur T, Demirpolat G, Tuncel D, et al. Carpal tunnel syndrome in patients with thyroid dysfunction: Ultrasonographic and electrophysiologic evaluation. Ege Journal of Medicine. 2014;53(1):19-24. doi:10.19161/etd.344035
Akarsu EO, Acar H, Özer F, et al. Electromyographic Findings in Overt Hypothyroidism and Subclinical Hypothyroidism. Turkish Journal of Neurology. 2013;19: 128-133. doi:10.4274/Tnd.13471
Chisholm JC Jr. Hypothyroidism: a rare cause of the bilateral carpal tunnel syndrome--a case report and a review of the literature. Journal of the National Medical Association. 1981;73(11):1082-1085.
Hayes EP, Carney K, Wolf J. Carpal tunnel syndrome. In: Mackin EJ, Callahan AD, Skirven TM, Schneider LH, Osterman AL, editors. Rehabilitation of the Hand and Upper Extremity. St Louis, Mosby; 2002. p. 643-57.
Goodyear-Smith F, Arroll B. What can family physicians offer patients with carpal tunnel syndrome other than surgery? A systemic review of nonsurgical management. Annals of Family Medicine. 2004; 2:267-273.doi: 10.1370/afm.21
Şakı MC, Ersen B, Tunalı O, et al. Dupuytren Kontraktürü: 87 Olgunun Retrospektif İncelenmesi. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2014; 40(1): 19-21.
Papanas N, Maltezos E. The diabetic hand: a forgotten complication? Journal of Diabetes and Its Complications. 2010;24(3):154-162. doi: 10.1016/j.jdiacomp.2008.12.009.
Özkaya Ö, Yeşilada AK, Karşıdağ S, et al. Dupuyten Kontraktürü: Etiyoloji, Tanı ve Cerrahi Tedavisi, On Yıllık Retrospektif Analiz: Turkiye Klinikleri Journal of Medical Sciences. 2010;30(2):553-558. doi: 10.5336/medsci.2008-9803
Cakir M, Samanci N, Balci N, et al. Musculoskeletal manifestations in patients with thyroid disease. Clinical Endocrinology. 2003;59(2):162-167. doi: 10.1046/j.1365-2265.2003.01786.x.
Grey RG. The natural history of "idiopathic" frozen shoulder. The Journal of Bone and Joint Surgery. 1978;60(4):564. PMID: 670287.
Manske RC, Prohaska D. Diagnosis and management of adhesive capsulitis. Current Reviews in Musculoskeletal Medicine. 2008;1(3-4):180-189. doi: 10.1007/s12178-008-9031-6.
Çelik D. Donuk omuz ve rehabilitasyonu. Turkiye Klinikleri Physiotherapy and Rehabilitation - Special Topics. 2017;3(1):23-29.
Wang K, Ho V, Hunter-Smith DJ, et al. Risk factors in idiopathic adhesive capsulitis: a case control study. The Journal of Shoulder and Elbow Surgery. 2013;22(7):e24-29. doi: 10.1016/j.jse.2012.10.049.
Summers GD, Gorman WP. Bilateral adhesive capsulitis and Hashimoto's thyroiditis. British Journal of Rheumatology.1989;28(5):451. doi: 10.1093/rheumatology/28.5.451.
Reuters VS, Teixeira Pde F, Vigário PS, et al. Functional capacity and muscular abnormalities in subclinical hypothyroidism. The American Journal of The Medical Sciences. 2009;338(4):259-263. doi: 10.1097/MAJ.0b013e3181af7c7c.
Cohen C, Tortato S, Silva OBS, et al. Association between Frozen Shoulder and Thyroid Diseases: Strengthening the Evidences. Revista Brasileira de Ortopedia. 2020;55(4):483-489. doi: 10.1055/s-0039-3402476.
Waltuck j. Musculoskeletal manifestations of thyroid disease. Bulletin on the Rheumatic Diseases. 2000;49(11):1-3.
Harvey RD, McHardy KC, Reid IW, et al. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. Journal of Clinical Endocrinology and Metabolism. 1991;72(6):1189-94. doi: 10.1210/jcem-72-6-1189.
Cooper DS, Kaplan MM, Ridgway EC, et al. Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Annals of Internal Medicine. 1979;90(2):164-8. doi: 10.7326/0003-4819-90-2-164.
Uzzan B, Campos J, Cucherat M, et al. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. Journal of Clinical Endocrinology and Metabolism. 1996;81(12):4278-89. doi: 10.1210/jcem.81.12.8954028.
Sindel D. Sekonder osteoporoz. İçinde: Gökçe-Kutsal Y, editör. Modern Tıp Seminerleri: 19, Osteoporoz. Ankara: Güneş Kitabevi; 2001. s. 66-81.
Auwerx J, Bouillon R. Mineral and bone metabolism in thyroid disease: a review. The Quarterly Journal of Medicine. 1986;60(232):737-752.
Dickson JA, Crosby EH. Periarthritis of the shoulder: an analysis of 200 cases. The Journal of the American Medical Association. 1932;99:2252-2257. doi:10.1001/JAMA.1932.02740790022007
Weiss JJ, Thompson GR, Woodbury D. Hyperthyroidism presenting as acute shoulder pain. Michigan Medicine. 1973;72:771-774.
Başak G, Samancı Karaman N. Tiroid hastalıklarında kas iskelet sistemi sorunları. Balcı N, editör. Endokrin Hastalıklarında Kas İskelet Sistemi Tutulumu. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.34-9.
Duyff RF, Van den Bosch J, Laman DM, et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. Journal of Neurology, Neurosurgery and Psychiatry. 2000;68(6):750-755. doi: 10.1136/jnnp.68.6.750.
Klein I, Ojamaa K. Thyroid (neuro)myopathy. Lancet. 2000;356(9230):614. doi: 10.1016/s0140-6736(00)02601-5.
Anderson CK, Miller OF 3rd. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease. The Journal of the American Academy of Dermatology. 2003;48(6):970-972. doi: 10.1067/mjd.2003.323.
Jadidi J, Sigari M, Efendizade A, et al. Thyroid acropachy: A rare skeletal manifestation of autoimmune thyroid disease. Radiology case reports. 2019;14(8),917–919. doi.org/10.1016/j.radcr.2019.04.021
Yılmaz N, Ok PG. Differential Diagnosis of Thyroid Dermopathy and Acropachy with Arthritis. Turkish Journal Of Osteoporosis. 2021;27:44-47. doi: 10.4274/tod.galenos.2020.90377
Fatourechi V, Ahmed DD, Schwartz KM. Thyroid acropachy: report of 40 patients treated at a single institution in a 26-year period. Journal of Clinical Endocrinology and Metabolism. 2002;87(12):5435-5441. doi: 10.1210/jc.2002-020746.
Bartalena L, Fatourechi V. Extrathyroidal manifestations of Graves' disease: a 2014 update. Journal of Endocrinological Investigation. 2014;37(8):691-700. doi: 10.1007/s40618-014-0097-2.
Ferreira-Hermosillo A, Casados-V R, Paúl-Gaytán P, et al. Utility of rituximab treatment for exophthalmos, myxedema, and osteoarthropathy syndrome resistant to corticosteroids due to Graves' disease: a case report. Journal of Medical Case Reports. 2018;12(1):38. doi:10.1186/s13256-018-1571-9
Türke B, Balázs C. Praetibialis myxoedema kezelése pentoxifillinnel [Treatment of pretibial myxoedema with pentoxifylline]. Orvosi Hetilap. 2012;153(43):1719-1722. doi: 10.1556/OH.2012.29472.
Finamor FE, Martins JR, Nakanami D, et al. Pentoxifylline (PTX)--an alternative treatment in Graves' ophthalmopathy (inactive phase): assessment by a disease specific quality of life questionnaire and by exophthalmometry in a prospective randomized trial. European Journal of Ophthalmology. 2004;14(4):277-283.
Yılmaz N, Ok PG. Differential Diagnosis of Thyroid Dermopathy and Acropachy with Arthritis. Turkish Journal Of Osteoporosis. 2021;27:44-47. doi: 10.4274/tod.galenos.2020.90377
Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. Journal of Clinical Endocrinology and Metabolism. 2006;91(7):2490-2495. doi: 10.1210/jc.2006-0356.
Marx A, Ruppersberg JP, Pietrzyk C,et al. Thyrotoxic periodic paralysis and the sodium/potassium pump. Muscle & Nerve. 1989;12:810-815. doi: 10.1002/mus.880121005.
Chan A, Shinde R, Chow CC, et al. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. British Medical Journal. 1991;2;303(6810):1096-1099. doi: 10.1136/bmj.303.6810.1096.
Robazzi TC, Adan LF. Autoimmune thyroid disease in patients with rheumatic diseases. Revista Brasileira de Reumatologia. 2012;52(3):417-430.
Raterman HG, Nurmohamed MT. Hypothyroidism in rheumatoid arthritis--to screen or not to screen? The Journal of Rheumatology. 2012;39(5):885-886. doi: 10.3899/jrheum.120015.
Chan AT, Al-Saffar Z, Bucknall RC. Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2001;40(3):353-354. doi: 10.1093/rheumatology/40.3.353.
El-Sherif WT, El Gendi SS, Ashmawy MM, et al. Thyroid disorders and autoantibodies in systemic lupus erythematosus and rheumatoid arthritis patients. Egyptian journal of immunology. 2004;11(2):81-90.
Innocencio RM, Romaldini JH, Ward LS. High prevalence of thyroid autoantibodies in systemic sclerosis and rheumatoid arthritis but not in the antiphospholipid syndrome. Clinical Rheumatology. 2003;22(6):494. doi: 10.1007/s10067-003-0803-5.
Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine. 2004;71(4):275-283. doi: 10.1016/j.jbspin.2003.06.005.
Sarı RA, Şahin M, Çapoğlu İ, et al. Frequency of autoimmune thyrioidit in the patients with collagen tissue disease. The Eurasian Journal of Medicine. 2000;32: 5-7.
Marasini B, Massarotti M. Rheumatoid arthritis and thyroid disease. Clinical and Experimental Rheumatology. 2004;22:265-266.
Shiroky JB, Cohen M, Ballachey ML, et al. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Annals of the Rheumatic Diseases. 1993;52(6):454-456. doi:10.1136/ard.52.6.454
Buchanon WW, Crooks J, Alexander WD, et al. Association of Hashimoto’s thyroiditis and rheumatoid arthritis. Lancet. 1961;1:245-248.
Silman AJ, Ollier WE, Bubel MA. Autoimmune thyroid disease and thyroid autoantibodies in rheumatoid arthritis patients and their families. British Journal of Rheumatology. 1989;28(1):18-21. doi: 10.1093/rheumatology/28.1.18.
Çefle A, Yazıcı A, Erkol B. thyroid function tests and their relation to disease activity in rheumatoid arthritis. Journal of İstanbul Faculty of Medicine. 2007;70:103-106
Stichweh D, Pascual V. Systemic lupus erythematosus in children. Annales de Pediatrie. 2005; 63:321-329. doi: 10.1157/13079833.
Mir S. Sistemik lupus eritematozus. Turkiye Klinikleri Journal of Pediatrics-Special Topics. 2003;1(1):29-36
Büyükberber S, Şencan O, Büyükberber N, et al. Sistemik lupus eritematozusda anormal tiroid fonksiyon testi sonuçları. Journal of Turgut Özal Medical Center. 1996;3(2):80-84
Pyne D, Isenberg DA. Autoimmune thyroid disease in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2002;61(1):70-72. doi: 10.1136/ard.61.1.70.
Arnaout MA, Nasrallah NS, el-Khateeb MS. Prevalence of abnormal thyroid function tests in connective tissue disease. Scandinavian Journal of Rheumatology. 1994;23(3):128-132. doi: 10.3109/03009749409103044.
Morita S, Arima T, Matsuda M. Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases. Journal of Clinical Endocrinology and Metabolism. 1995;80(4):1203-1206. doi: 10.1210/jcem.80.4.7714090.
Aksu K. Sjögren sendromunda immun supresif tedavi. Raed Dergisi. 2009;1:35-41
Jara LJ, Navarro C, Brito-Zerón Mdel P, et al. Thyroid disease in Sjögren's syndrome. Clinical Rheumatology. 2007;26(10):1601-1606. doi: 10.1007/s10067-007-0638-6.
Lazarus MN, Isenberg DA. Development of additional autoimmune diseases in a population of patients with primary Sjogren’s syndrome. Annals of the Rheumatic Diseases. 2005;64(7):1062–1064. doi:10.1136/ard.2004.029066
Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, et al. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Diseases. 2012;2012:254319. doi:10.1155/2012/254319
Teixeira Mendes LS, Wotherspoon A. Marginal zone lymphoma: associated autoimmunity and auto-immune disorders. Best Practice and Research in Clinical Haematology . 2017;30(1–2):65–76. doi:10.1016/j.beha.2016.07.006
López-Pousa S, Garre-Olmo J, de Gracia M, et al. Development of a multidimensional measure of fibromyalgia symptomatology: The comprehensive rating scale for fibromyalgia symptomatology. Journal of Psychosomatic Research. 2013;74(5):384-392. doi: 10.1016/j.jpsychores.2012.12.018.
Bazzichi L, Rossi A, Zirafa C, et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatology International. 2012;32(2):335-341. doi: 10.1007/s00296-010-1620-1.
Russell IJ, Michalek JE, Xiao Y, et al. Therapy with a central alpha 2-adrenergic agonist (tizanidine) decreases cerebrospinal fluid substance P, and may reduce serum hyaluronic acid as it improves the clinical symptoms of the fibromyalgia syndrome. Arthritis and Rheumatology. 2002;46, 614.
Suk JH, Lee JH, Kim JM. Association between thyroid autoimmunity and fibromyalgia. Experimental and Clinical Endocrinology and Diabetes. 2012;120(7):401-404. doi: 10.1055/s-0032-1309008.
Bazzichi L, Rossi A, Zirafa C, et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatology International. 2012;32(2):335-341. doi: 10.1007/s00296-010-1620-1.
Ciregia F, Giacomelli C, Giusti L, Bazzichi L, Lucacchini A. Diagnosis of Fibromyalgia Syndrome:Potential Biomarkers and Proteomic Approach. In New Insights into Fibromyalgia; Eilke, W.S., Ed.; Intech: London, UK, 2012
Kültür T, Durmaz ŞA. Fibromiyalji ve Tiroid Disfonksiyonu. Ortadogu Medical Journal. 2015;7 (2): 91-94.
Karaoğullarından Ü, Tarhan EF, Oruk G. Frequency of autoimmune thyroid disorders in patients with psoriatic arthritis and effect of anti-TNF alpha treatment. Cukurova Medical Journal 2020;45(2):461-467. doi: 10.17826/cumj.669775
